Described herein are compounds of Formula (I) and pharmaceutically acceptable salts thereof, as well as pharmaceutical compositions thereof. Compounds of the present invention are useful for inhibiting PRMT5 activity and may have use in treating proliferative, such as cancer, metabolic and blood disorders. Compounds of Formula (I) have the following structure of Formule (I).
本文描述了公式(I)的化合物及其药学上可接受的盐,以及其药物组成物。本发明的化合物可用于抑制PR
MT5活性,并可用于治疗增殖性疾病,如癌症、代谢和血液疾病。公式(I)的化合物具有以下结构公式(I)。